Questions for Public-Private Pact That Led to Xeljanz
Tuesday, March 19, 2013 - 00:10
in Mathematics & Economics
Congress wants a second look at how private firms profit from public research after Pfizer and the N.I.H. developed a potentially lucrative new drug.